LifePulse Corporation develops and manufactures its US-engineered Intellipulse® platform to deliver therapeutics directly into cells, with a focus on targeted oncology in human and veterinary medicine. Founded by Gary Strange, the Tampa Bay company builds on more than three decades of research, $35 million in non-dilutive funding, and over 100 issued patents. Its animal-health division has treated hundreds of dogs, cats, and horses since 2022, while its human-health program is advancing toward pancreatic-tumor trials.
SpectraVETFounded by Peter Jenkins in 1996, SpectraVET designs and manufactures veterinary therapeutic laser and LED devices for photobiomodulation, serving performance animals, pets, and wildlife. The company began with greyhound and medical acupuncture lasers, then specialized in veterinary lasers in 1999; since establishing SpectraVET Inc. in the United States in 2005, it has expanded its product range and worldwide service network while continuing to study and teach photobiomodulation.COEYMANS HOLLOW, NY
Kubanda CryotherapyFounded by biomedical engineers from Johns Hopkins, Baltimore-based Kubanda Cryotherapy develops cryoablation technology for minimally invasive treatment of tumors in pets. Its point-of-care system uses a cryoprobe and gas-control module to freeze unwanted tissue as an alternative to surgical resection, and the company supports veterinary practices with clinical research and education.BALTIMORE, MD
MesaGreen Pharmaceutical CompanyMesaGreen Pharmaceutical Company is a virtual animal-health pharmaceutical developer creating an at-home emergency treatment for breakthrough seizures in dogs. The Frederick company is developing its K9MGP product around an auto-injection system intended to deliver rapid rescue therapy, drawing on human drug-delivery experience and veterinary research. MesaGreen is a small veteran-owned business and a wholly owned subsidiary of Mesa Science Associates.FREDERICK, MD
Intrance Medical Systems, IncFounded in 2018 by Parkinson’s specialists Ulf Rosén and Roger Bolsöy, Intrance Medical Systems is a U.S.-based biopharmaceutical company developing and commercializing a drug-device therapy for advanced Parkinson’s disease. Its lead product, known as Lecigon® in Europe, pairs a proprietary carbidopa, entacapone and levodopa gel with a lightweight wearable pump that delivers continuous treatment directly to the small intestine. The company has FDA clearance for its IND application and controls commercial rights in the United States and several other international markets.